Proteins and Peptides

17 Jan 2007 Neose Receives Approval to Commence Phase II Clinical Trial For NE-180
16 Jan 2007 Genzyme Announces Publication of Study Showing Impact of Cerezyme on Bone Health for Patients with Type 1 Gaucher Disease
16 Jan 2007 FDA accepts for filing a New Drug Application (NDA) for Somatuline(R) Autogel(R)
16 Jan 2007 Novo Nordisk focuses research and development on therapeutic proteins - discontinues R&D within small molecules
12 Jan 2007 ELAPRASE for the treatment of Hunter syndrome approved by the European Commission
12 Jan 2007 Protherics PLC announces Voraxaze(TM) Update
11 Jan 2007 Astellas Terminates Agreement on Acute Heart Failure Agent Carperitide
11 Jan 2007 NeoRecormon gains European approval for convenient once weekly treatment of anaemia in patients with solid cancers
11 Jan 2007 Sembiosys’ Plant-Produced Insulin Chemically And Physiologically Equivalent To Commericial Insulin In Animal Studies
10 Jan 2007 Aida Pharmaceuticals Receives Approval and Commences Phase II Trials of Potential Cancer Treatment
10 Jan 2007 XOMA Initiates Clinical Trial of NEUPREX At Harvard Medical School in Allogeneic Hematopoietic Stem Cell Transplantation
09 Jan 2007 Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration
09 Jan 2007 Æterna Zentaris Initiates First Study of Phase 3 Program with Cetrorelix in BPH - 600 Patient Trial Conducted in the United States and Canada
09 Jan 2007 Allon drug selected for clinical trial in the treatment of cognitive impairment in schizophrenia
09 Jan 2007 ThromboGenics Initiates Phase IIb U.S. Clinical Trial of Microplasmin in Vitrectomy
08 Jan 2007 Catalyst Biosciences And Wyeth Pharmaceuticals Sign Two Agreements For Novel Biotherapeutic Platform Of Engineered Proteases
05 Jan 2007 Nuvelo Initiates Phase 2 Trial of rNAPc2 in Patients with Metastatic Colorectal Cancer
05 Jan 2007 BioAxone Therapeutic Licenses Phase II Spinal Cord Injury Drug Cethrin(R) to Boston Life Sciences
04 Jan 2007 FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use
04 Jan 2007 Spectrum Pharmaceuticals Announces FDA's Acceptance of Ozarelix IND and Approval of Phase 2b Protocol in BPH (Benign Prostate Hypertrophy)
04 Jan 2007 CoGenesys Files to Begin Clinical Trials of Neugranin for the Prevention of Infections in Cancer Patients
04 Jan 2007 Five Prime enters Osteoarthritis and Pulmonary Fibrosis Collaboration with Centocor

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up